Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection
Advanced Science · 2023-09 · 10 (27)
DOI: 10.1002/advs.202301930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.07.2023. Verfasst von Ala Jo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Detecting early cancer through liquid biopsy is challenging due to the lack of specific biomarkers for early lesions and potentially low levels of these markers. The current study systematically develops an extracellular‐vesicle (EV)‐based test for early detection, specifically focusing on high‐grade serous ovarian carcinoma (HGSOC). The marker selection is based on emerging insights into HGSOC pathogenesis, notably that it arises from precursor lesions within the fallopian tube. This work thus establishes murine fallopian tube (mFT) cells with oncogenic mutations and performs proteomic analyses on mFT‐derived EVs. The identified markers are then evaluated with an orthotopic HGSOC animal model. In serially‐drawn blood of tumor‐bearing mice, mFT‐EV markers increase with tumor initiation, supporting their potential use in early cancer detection. A pilot clinical study ( n = 51) further narrows EV markers to five candidates, EpCAM, CD24, VCAN, HE4, and TNC. The combined expression of these markers distinguishes HGSOC from non‐cancer with 89% sensitivity and 93% specificity. The same markers are also effective in classifying three groups (non‐cancer, early‐stage HGSOC, and late‐stage HGSOC). The developed approach, for the first time inaugurated in fallopian tube‐derived EVs, could be a minimally invasive tool to monitor women at high risk of ovarian cancer for timely intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
- Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
- Center for Nanomedicine, Institute for Basic Science, Seoul, 03722, Republic of Korea.
- Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
- Biostatistics Center, Massachusetts General Hospital, Boston, MA, 02114, USA.
ORCID-Profile: Hakho Lee
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NIDA NIH HHS
- National Science Foundation
- U.S. Department of Defense
Zitieren
APA
Jo, A., Green, A., Medina, J. E., Iyer, S., Ohman, A. W., McCarthy, E. T., Reinhardt, F., Gerton, T., Demehin, D., Mishra, R., Kolin, D. L., Zheng, H., Cheon, J., Crum, C. P., Weinberg, R. A., Rueda, B. R., Castro, C. M., Dinulescu, D. M., & Lee, H. (2023). Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection. Advanced Science, 10(27). https://doi.org/10.1002/advs.202301930
Vancouver
Jo A, Green A, Medina JE, Iyer S, Ohman AW, McCarthy ET, et al. Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection. Advanced Science. 2023;10(27). doi:10.1002/advs.202301930
BibTeX
@article{Jo2023,
author = {Jo, Ala and Green, Allen and Medina, Jamie E and Iyer, Sonia and Ohman, Anders W and McCarthy, Eric T and Reinhardt, Ferenc and Gerton, Thomas and Demehin, Daniel and Mishra, Ranjan and Kolin, David L and Zheng, Hui and Cheon, Jinwoo and Crum, Christopher P and Weinberg, Robert A and Rueda, Bo R and Castro, Cesar M and Dinulescu, Daniela M and Lee, Hakho},
title = {Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {27},
doi = {10.1002/advs.202301930}
}
EUVIMED